A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy Adults
NCT07047521
·
clinicaltrials.gov ↗
PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
496
Enrollment
INDUSTRY
Sponsor class
Conditions
Dengue Fever
Interventions
BIOLOGICAL:
Tetravalent Dengue Vaccine (TDV)
Sponsor
Takeda